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Abstract We report the isolation and characterisation of a
novel opsin cDNA from the retina and pineal of the common carp
(Cyprinus carpio L.). When a comparison of the amino acid
sequences of salmon vertebrate ancient opsin (sVA) and the novel
carp opsin are made, and the carboxyl terminus is omitted, the
level of identity between these two opsins is 81% and represents
the second example of the VA opsin family. We have therefore
termed this C. carpio opsin as carp VA opsin (cVA opsin). We
show that members of the VA opsin family may exist in two
variants or isoforms based upon the length of the carboxyl
terminus and propose that the mechanism of production of the
short VA opsin isoform is alternative splicing of intron 4 of the
VA opsin gene. The VA opsin gene consists of five exons, with
intron 2 significantly shifted in a 3P direction relative to the
corresponding intron in rod and cone opsins. The position (or
lack) of intron 2 appears to be a diagnostic feature which
separates the image forming rod and cone opsin families from the
more recently discovered non-visual opsin families (pin-opsins
(P), vertebrate ancient (VA), parapinopsin (PP)). Finally, we
suggest that lamprey P opsin should be reassigned to the VA
opsin family based upon its level of amino acid identity, genomic
structure with respect to the position of intron 2 and nucleotide
phylogeny.
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1. Introduction
Based upon cDNA sequences, the well-characterised opsin
families of the vertebrates appear to have emerged in the
following phylogenetic sequence: long wavelength cone opsins
(L), pin-opsins (P), violet cone opsins (S), blue cone opsins
(M1), green cone opsins (M2) and ¢nally rod opsins (Rh) [1].
The genomic structure of S [2], M1 [3], M2 [4] and Rh [5]
opsins are identical ; they all contain four introns at equivalent
coding positions (designated in this paper as 1, 2, 3 and 4).
The genomic structure of P and L opsins, however, are
slightly di¡erent. In the P opsins the second intron is dis-
placed 14 nucleotides in the 3P direction [6], whilst the L
opsins contain an additional intron site [2], designated as 0
in this paper. In addition, the recently discovered parapinop-
sin (PP) shows a yet further di¡erence in its genomic structure
lacking the second intron of the Rh, M1, M2 and S opsins [7].
The signi¢cance of these di¡erences in the genomic structure
is unknown. They may represent changes that were introduced
when P, L and PP opsins were duplicated from an ancestral
gene. Alternatively, they may represent post-duplication
events speci¢c to P, L and PP opsin families. Either way, these
di¡erences in genomic structure appear to serve as additional
features to di¡erentiate the opsin families of the vertebrates.
We have described previously the primary structure of a
novel ocular cDNA isolated from the eye of Atlantic salmon
(Salmo salar) which was the single member of a new opsin
family named the vertebrate ancient (VA) opsin family [8].
Salmon VA (sVA) opsin forms a functional photopigment
with a maximal absorbance of 451 nm and is expressed in a
subset of retinal cells with the location and morphology char-
acteristic of horizontal and amacrine cells [9]. Additionally
sVA opsin is also expressed within cells of the pineal gland
and the sub-habenular region of the brain [10]. These diverse
sites of VA opsin expression, taken together with several
unique features present in its amino acid sequence, suggested
that VA opsin is a novel photopigment specialised for non-
image forming light detection [8].
To date, the only available VA opsin sequence is that de-
scribed for ocular sVA opsin and no information currently
exists on the genomic structure of this gene. Furthermore,
preliminary data suggests that VA opsin may exist in two
variants with either a short or a long carboxyl terminus
[11,12]. We have therefore undertaken a detailed study of
another member of the VA opsin family from the common
carp (Cyprinus carpio L.), a species that is widely used in
teleost retinal electrophysiology. In this paper we report and
consider: (i) the isolation and characterisation of carp VA
opsin (cVA opsin) from both retinal and pineal tissues; (ii)
the ¢nding that VA opsin is present in two carboxyl terminus
variants in teleosts; (iii) the genomic structure of VA opsin in
both carp and salmon and, ¢nally, (iv) we provide evidence
that the previously described genomic sequence isolated from
lamprey (Petromyzon marinus) and termed Lamprey P opsin
is, in fact, a member of the VA opsin family.
2. Materials and methods
2.1. Isolation of cVA opsin cDNA
Poly(A)+mRNA was isolated from retinae and pineal glands of the
common carp (C. carpio L.) using the QuickPrep Micro mRNA Kit
(Pharmacia). Retinal and pineal cDNA was synthesised using the 3P
RACE System (Life Technologies).
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A 363 bp VA opsin cDNA fragment was ampli¢ed using degenerate
primers VM1, 5P-TAYTTYGTIATHTGYCGICCICTIGG-3P (corre-
sponding to the following amino acid sequence of sVA opsin, Tyr-138
to Gly-146), and VM2, 5P-IGCCATRTACATSACSACSACCAT-3P
(complementary to amino acid sequence of sVA opsin, Ala-258 to
Met-251). Polymerase chain reaction (PCR) ampli¢cation was per-
formed using BioTaq polymerase (Bioline) in the manufacturers
NH4 bu¡er at 3.0 mM MgCl2. The following thermal pro¢le was
used: an initial denaturation step of 3 min at 94‡C, followed by 35
cycles of 1 min at 94‡C, 1.5 min at 53‡C and 1.5 min at 72‡C.
The 3P region of the cDNA was recovered using the following gene
speci¢c primers in conjunction with the 3P RACE System (Life Tech-
nologies): VM3, 5P-CTCGCTGTGATCATCGTCT-3P (primary
PCR), and VM4, 5P-TCTAACACGCACGGCAGGCT-3P(secondary
PCR). The 5P end of the cDNA was obtained using the following
gene speci¢c primers in conjunction with the 5P RACE System (Life
Technologies): VM5, 5P-GTCCAGACGAAGGAGAA-3P (cDNA
synthesis), VM6, 5P-CAGACCCAGAGCTGCATGCTT-3P (primary
PCR), and VM7 5P-CTTTCCTCGCAGACGGATGT-3P (secondary
PCR).
All PCR products were ligated into pGEM-T-Easy Vector (Prom-
ega) and transformed into DH5K Sub-Cloning E⁄ciency Competent
Cells (Life Technologies). Nucleotide sequence determination was car-
ried out on an ABI PRISM 377 DNA Sequencer (Perkin Elmer) using
the ABI PRISM BigDye Terminator Cycle Sequencing Kit (Perkin
Elmer). The cloned products from three independent PCR ampli¢ca-
tions were sequenced on both DNA strands.
The full length coding region of VA opsin was PCR ampli¢ed from
retinal cDNA using primers directed against the 5P and 3P untrans-
lated regions of the gene: VMVA1, 5P-GATGCACGCAGACTT-
CTTCCA-3P and VMVA2, 5P-CGCTGGATGAAGGTCATTTAG-3P
2.2. Determination of exon/intron structure
High molecular weight genomic DNA was isolated from C. carpio
brain tissue using the soft tissue protocol of the Nucleon DNA Ex-
traction Kit (Nucleon Biosciences, UK). PCR ampli¢cation was per-
formed on 50 ng of genomic DNA as described previously using
primer pairs designed to encompass the entire coding sequence. The
following primer pairs were designed to encompass the putative intron
insertion sites based upon the genomic structure of Rh opsin [5]: exon
1, VM8F, 5P-ATGGAGTCGTTGGCTGCG-3P and exon 2, VM11R,
5P-GATGACGAAGAACCGCTCGAA-3P ; exon 2, VM12F, 5P-AT-
CGTGGCGCTGTGG-3P and exon 3, VM13R, 5P-TGAGCTTGCG-
GAGCAGTTTGC-3P ; exon 3, VM14F, 5P-TTCATCATCACGTT-
CTTCACC-3P and exon 4, VM15R, 5P-TGTAAACCGCTGCAG-
TTTTGG-3P ; exon 4, VM16F, 5P-ACTCGTATGGTGGTTGTGAT-
GATC-3P and exon 5, VM19R, 5P-CATCGGACATACTTTGTT-
CTC-3P.
2.3. Phylogenetic analysis
Nucleotide and amino acid alignments were carried out using the
ClustalX 1.8 suite of programs using default values ([13]; ftp://ftp-
igbmc.u-strasbg.fr/pub/ClustalX/). For phylogenetic purposes, the nu-
cleotide alignments were adjusted using the SeaView program to
maintain codon integrity prior to analysis in the Phylo_win package
(both programs- [14]; http://pbil.univ-lyon1.fr/). Maximum parsimony
and neighbour-joining trees were constructed with bootstrap con¢-
dence values based on 1000 replicates.
3. Results and discussion
3.1. Characterisation of VA opsin from the common carp
(C. carpio)
Using a combination of degenerate primer PCR and 3P and
5P RACE PCR techniques, we isolated the complete coding
sequence of an opsin-like cDNA from the retina of the com-
mon carp, C. carpio. The cDNA possesses a 1149 bp open
reading frame predicting a 382 amino acid protein (Fig. 1).
The complete nucleotide coding sequence and the predicted
Fig. 1. Nucleotide sequence and conceptual translation of cVA op-
sin cDNA (GenBank: AF233520). The nucleotide coding sequence
is presented in upper case and the 5P and 3P untranslated regions in
lower case, with the predicted polypeptide shown as the single letter
code below the nucleotide sequence. The translation stop-codon is
designated by the asterisk and the polyadenylation signal is under-
lined. The seven transmembrane K-helices as predicted by the model
of Baldwin et al. [32] are shaded.
Table 1
Comparison of amino acid positions in Rh opsin implicated in the binding or activation of Gt, with those of cVA opsin
Opsin domain Amino acid position in bovine Rh
opsin
Substitution e¡ect Equivalent position in cVA opsin Reference
Second cytoplasmic loop E134, R135 no Gt binding E127, R128 [34^37]
Third cytoplasmic loop L226, T243 no Gt activation L217, A234 [34,35,38]




K220, L221, V224, S225, N233,
R235
Transmembrane domain VII and
cytoplasmic tail
Y306 no Gt activation Y297 [17,34,39]




V298, M300, N301, K302, Q303,
F304, V308
The biochemical e¡ect observed in Rh opsin when substitutions are made at these positions is noted.
FEBS 23682 11-5-00
P. Moutsaki et al./FEBS Letters 473 (2000) 316^322 317
amino acid translation opsin share 60 and 66% identity, re-
spectively, with the VA opsin isolated from the Atlantic sal-
mon, S. salar (sVA) [8]. Signi¢cantly, the carboxyl terminus
(the cytoplasmic tail region after the seventh transmembrane
domain) of the C. carpio opsin is 79 amino acid residues in
length, whereas the corresponding region in sVA opsin is 13
residues long (see Fig. 2). When a comparison of the C. carpio
opsin and sVA opsin amino acid sequences are made, and the
carboxyl terminus is omitted, the level of identity between
these two opsins increases to 81%. We have therefore termed
this C. carpio opsin as cVA opsin. It seems, therefore, that the
members of the VA opsin family exist in two variants, a long
and a short carboxyl terminus, cVA opsin being an example
of the long form and sVA opsin of the short form.
3.2. Key features in the amino acid sequence of VA opsin
The predicted cVA opsin amino acid sequence retains, like
that of sVA opsin, the conserved features required for opsin
function^retinal attachment site (Lys287) located in trans-
membrane domain VII; the Schi¡ base counterion (Glu106)
in transmembrane domain III; cysteine residues at positions
103 and 180 required for conformational stability [8]. How-
ever, cVA opsin contains one probable palmitoylation site
(Cys-314) in its carboxyl terminus whereas sVA opsin has
no palmitocysteines (Fig. 2). The palmitocysteines in the rod
and the cone opsins are believed to be used as the site where
the C-terminal tail anchors to the plasma membrane creating
a fourth cytoplasmic loop [15,16]. The absence of palmitoyla-
tion sites in sVA opsin might relate to the greatly reduced
length of the carboxyl terminus, which does not need ‘anchor-
ing’ and presumably £oats freely in the cytoplasm. Removal
of palmitoylation sites in rod and cone opsins appears not to
disrupt the activation of the G-protein, transducin (Gt)
[16,17]. However, di¡erences in the length of the carboxyl
terminus of sVA and cVA may have an e¡ect on the dynamics
of the phototransduction cascade. Phosphorylation of serines
and threonines in the carboxyl terminal of rhodopsin (by rho-
dopsin kinase) is required for the termination phototransduc-
tion [18,19]. The long form of VA opsin in carp has an in-
creased number of serines and threonines (13 in total),
whereas only three are found in the short sVA opsin (Fig.
2). Thus, the increased number of phosphorylation sites in
the long form (cVA) may allow a rapid deactivation of the
G-protein mediated cascade, whereas the reduced number of
serines and threonines in the short form (sVA) may allow an
extended activation of the cascade.
Site directed mutagenesis studies have identi¢ed three spe-
ci¢c domains of the cytoplasmic surface of Rh opsin that are
known to be important in the binding and activation of Gt.
These domains and the amino acids associated with binding
Fig. 2. Partial amino acid alignment of sVA opsin, cVA opsin, lamprey P opsin, chicken P opsin and cat¢sh PP opsin. The alignment shown is
restricted to the seventh transmembrane domain (indicated by bar) and the carboxyl terminus (whose start is indicated by an arrow). Amino
acid identity is indicated by an asterisk. The plus sign (+) indicates the presence of possible palmitoylation cysteines, absent in sVA opsin.
Table 2
Exon/intron splice junctions for cVA opsin gene
Upper case letters represent coding sequence, lower case letters represent intron sequence. Numbers above sequence indicate the coding nucleo-
tides that surround the intron insertion site.
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and/or activation are reviewed in Table 1. Although some of
these key amino acid positions are conserved in cVA opsin,
several are not. This suggests that VA opsin may interact with
a unique form of G-protein. In common with other non-visual
opsins cVA opsin lacks a doublet of amino acids in the second
extra-cellular loop (Fig. 3) that are present in the image form-
ing (rod and cone) opsins [20].
3.3. Tissue expression of cVA opsin
To determine whether cVA opsin is expressed in the pineal
gland of C. carpio, we used gene speci¢c primers located at the
start and the end of the coding sequence of cVA opsin (VM8F
and VM19R) to amplify the entire coding sequence from pine-
al cDNA. The cDNA that we isolated from the pineal is
99.8% identical to that isolated from the retina. The nucleo-
tide substitutions that are present are silent in nature and may
occur due to the tetraploid nature of the C. carpio genome
[21]. A similar phenomenon has been observed in C. carpio,
where two Rh opsin alleles have been isolated from the retina
which are 97.2% identical [22,23]. The expression of cVA op-
sin in both the retina and pineal parallels our ¢nding with
sVA opsin [10].
3.4. Genomic organisation of cVA and sVA opsin
Using PCR primers designed to amplify introns based on
the genomic structure of other opsin classes [2,5^7,20], we
determined that the cVA opsin gene is approximately 8.2 kb
in length. The gene consists of ¢ve exons and all the introns
conform to the splice site consensus [24] (see Table 2). The
¢rst, third and fourth intron sites are at equivalent positions
to all of the other opsin families. The second intron, however,
is shifted 42 nucleotides in the 3P direction in comparison with
the Rh-like and L opsins, and 14 nucleotides in comparison to
P opsins. Although the second intron is absent in PP opsin [7],
it is apparent that the position (or absence) of intron 2 clearly
separates the M1, M2, Rh, S and L opsins (traditionally as-
sociated with the rod and cone photoreception) from P, PP
and VA opsins (which are not expressed in rod or cone photo-
receptors) (see Fig. 4). Whether intron 2 occurs at these di¡er-
ent sites as a result of intron slippage of a single ancestral
intron, or independent intron gain/loss in each of the lineages
[25] remains unclear.
We also determined the genomic structure of sVA opsin
and introns 1, 2 and 3 are inserted at similar locations to their
cVA opsin counterparts (data not shown), but intron 4 ap-
pears to be absent in the sVA opsin gene. Comparison of the
sVA opsin sequence with that of cVA opsin indicates that the
Fig. 3. Partial amino acid alignment of some of the non-visual photopigments that are found to date with that of the visual bovine Rh opsin.
The alignment shown is restricted between the end of the transmembrane IV and the beginning of the transmembrane domain V. The asterisks
denote the lack of a doublet of amino acids in all the non-visual opsins.
Fig. 4. A neighbour-joining tree of the di¡erent classes of opsins
(Rh, rod opsin; M1, blue cone opsin; M2, green cone opsin; S, ul-
traviolet cone opsin; L, red cone opsin; P, pin-opsin; PP, parapi-
nopsin; VA, vertebrate ancient opsin), constructed from nucleotide
data. Schematic representations of the intron positions in the di¡er-
ent opsin classes are indicated. Intron 0 is only present in the L
class opsins. Intron 2 varies in position depending on opsin class,
and may be absent, see text for details. The relative position of in-
tron 2 in the Rh/L class opsins is indicated by an arrow. The nucle-
otide neighbour-joining tree is corrected by the Kimura method [33]
and the scale bar is calibrated in substitutions per site. Bootstrap
con¢dence values are based on 1000 replicates. Cuttle¢sh rhodopsin
(Sepia o⁄cinalis, AF000947) and Calliphora erythrocephala Rh1 op-
sin (M58334) were used as an outgroup. Nucleotide accession num-
bers: zebra¢sh: AF109372, AF109369, AF104904, AF109373,
AF109368; gold¢sh: L11864, L11865, L11867, D85863, L11863;
Anolis : AF134767, AF134768, AF134769, AF134770, AF134771;
chicken: U15762; toad: AF200433; carp: AF233520; salmon:
AF001499; lamprey: U90667, U90668, U90669, U90670, U90671;
cat¢sh: AF028014.
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predicted insertion site of intron 4 occurs in the motif
....MNKQ-intron-FR.... This motif is highly conserved and
present in all opsin classes at the junction of the seventh trans-
membrane domain and the carboxyl terminus, but is disrupted
in sVA opsin occurring as MNKQVS. Inspection of the
cDNA sequence of sVA opsin reveals that the disruption of
the MNKQFR motif occurs at the predicted intron insertion
site present in cVA opsin (see Fig. 5A). Interestingly, the nu-
cleotide sequence of the sVA opsin carboxyl terminus and 3P
UTR shares approximately 44% identity with the initial se-
quence of cVA opsin intron 4 (see Fig. 5B). Analysis of the
sequence at the 5P region of cVA opsin intron 4 reveals two
potential polyadenylation signals are present that may lead to
an alternatively spliced transcript [26], forcing a read-through
at translation that will produce an open reading frame that
contains an MNKQVT motif followed by a potential carboxyl
terminus of 38 amino acids (see Fig. 5C). Signi¢cantly, the
NKQ tripeptide remains intact in sVA opsin, and this is likely
Fig. 5. Illustration of the possible mechanism for the production of the short and long VA opsin isoforms. A: Partial cDNA sequence and
translation of the sVA opsin carboxyl terminus. Coding sequence is in upper case and 3P UTR is in lower case. The predicted intron donor site
is shown in bold. The polyadenylation signal is underlined. B: Alignment of the sVA opsin cDNA sequence from (A) and a partial genomic se-
quence of exon IV and intron 4 of cVA opsin (with numeration relative to the cVA opsin cDNA, see Fig. 1). The intron sequence of cVA op-
sin shares 44% identity with the carboxyl terminus and 3P UTR cDNA sequence of sVA opsin (shaded). Asterisks indicate identity. C: Partial
genomic sequence and theoretical translation of exon IV and intron 4 of cVA opsin from (B) (with numeration relating to the amino acid
translation in Fig. 1). The cDNA coding sequence is shown in upper case, intron sequence in lower case and the hypothetical translation in
italic. Two potential polyadenylation signals that lie approximately 100 and 130 bp 3P of the potential stop codon are underlined.
FEBS 23682 11-5-00
P. Moutsaki et al./FEBS Letters 473 (2000) 316^322320
to be important, as it has recently been shown that disruption
of this tripeptide diminishes Gt activation in bovine Rh opsin
[17].
3.5. The relationship of VA opsin and lamprey P opsin
We compared the deduced amino acid sequences and the
genomic structure of both cVA opsin and an opsin isolated
from the marine lamprey, P. marinus, designated lamprey P
opsin [20]. This designation, however, may be misleading as
lamprey P opsin shows greater similarity to the VA opsins
than to the P opsins. Both the VA opsins and lamprey P opsin
retain all four introns and share a 42 bp shift in their second
intron site. This feature alone distinguished these opsins from
all other opsin families. Furthermore, a comparison of the
deduced amino acid sequences between chicken (Gallus gallus)
[27], toad (Bufo japonicus) [28] and American chameleon (Ano-
lis carolinensis) [29] P opsins shows an amino acid identity of
s 80%. Lamprey P opsin, however, shares only 46^48% iden-
tity with these P opsins. By contrast, lamprey P opsin shares
61 and 65% identity with sVA and cVA opsin, respectively.
Finally, the size of lamprey P opsin carboxyl terminus (124
amino acids) is more comparable to that of the cVA opsin (79
amino acids) than the rest of the P opsins (43 amino acids in
pigeon P opsin [30] and 56 amino acids in chameleon P opsin
[29]). One parsimonious explanation for these data, especially
in light of the evolutionary position of lampreys, is that lamp-
rey P opsin is the evolutionary precursor of the VA opsin
family. The hypothesis is further supported by the phyloge-
netic placement (based upon nucleotide coding sequences) of
lamprey P opsin, sVA opsin and sVA opsin within the same
clade (Fig. 4).
VA opsin has been isolated from both a marine ¢sh (At-
lantic salmon) and a fresh water ¢sh (carp). Furthermore,
Southern blot analysis was performed on the DNA from a
deep-sea ¢sh (bristlemouth) and zebra¢sh, and potential VA
opsin orthologues were found in both species (data not
shown). It also appears that lampreys have an orthologue of
VA opsin (see discussion above). These ¢ndings suggest that
VA opsin is widely distributed amongst the teleosts and agna-
tha. By contrast, our preliminary high stringency Southern
analysis failed to ¢nd potential VA orthologues in birds and
several species of mammal (data not shown). We are currently
extending this analysis to include amphibian and reptilian
species. It is interesting that P opsin orthologues have been
reported in birds [27], reptiles [29] and amphibia [28], but have
not been found in teleost ¢sh [29]. If VA opsins and P opsins
were performing some common photosensory task then their
non-overlapping taxonomic distribution might be expected.
Further physiological analysis will be required to clarify this
possibility.
4. Note added in proof
Since this work was accepted for publication we have learnt
that similar work carried out on the zebra¢sh (Danio rerio)
has produced two VA opsin isoforms that have homologies to
the short carboxyl terminus sVA opsin (termed zVA opsin)
and the long carboxyl terminus cVA opsin (termed zVALong
opsin) [31]. The carboxyl terminus of zVAL opsin is 74 amino
acids in length and shares 73.5% identity with the 79 amino
acid carboxyl terminus of cVA opsin, whereas the carboxyl
terminus of zVA opsin is 7 amino acids long and is compa-
rable to the 13 amino acid carboxyl terminus of sVA opsin.
The authors of this paper suggest a similar alternative splicing
mechanism to the one proposed in this paper for the produc-
tion of the two zebra¢sh VA opsin isoforms, and we antici-
pate that the 5P region of intron 4 of the zVAL gene will
contain the nucleotide sequence that encodes the short car-
boxyl terminus of zVA opsin and its associated 3P UTR and
polyadenylation mechanism.
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